ArcBest (ARCB) Misses Q1 EPS by 4c

ArcBest (NASDAQ: ARCB) reported Q1 EPS of $0.06, $0.04 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $613.3 million versus the consensus estimate of $621.27 million.

For earnings history and earnings-related data on ArcBest (ARCB) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c